The Outlook for Pharmaceuticals in Western Europe

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Key Pharma News 15 DECEMBER 2014

Key Pharma News 15 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 29 pages

Industry Trend Analysis - Merck Claims Leadership Of Revived Antibiotics Market With Cubist Acquisition Industry Trend Analysis - Pfizer Will Become Serious Contender In Immuno-Oncology Industry Brief - UCB/Daiichi Sankyo To Jointly Commercialise Lacosamide In Japan Industry Brief - Evotec/Sanofi In ...

Industries: Drug and Medication | Countries: South Korea, United States, Japan, World, Canada, Italy, China, Europe

Anti-Infective Drug News 08 DECEMBER 2014

Anti-Infective Drug News 08 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - Drugmakers Undertake Risks To Enable Ebola Vaccines To Reach Market Faster Industry Brief - FDA Approves Onexton Gel For Acne Vulgaris Industry Brief - Dificlir Proven To Be Clinically/Cost Effective Over SoC Treatments In CDI Industry Brief - Basilea Launches Zevtera In Germany ...

Industries: Drug and Medication | Countries: Italy, Germany, Europe

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • December 2014
  • 125 pages

BMI View: Turkey's pharmaceutical industry offers strong growth potential and will continue to be viewed as an attractive industry for foreign drugmakers, particularly those who are interested in the take over of the remaining (mainly private) domestic producers. However, when compared with other majo ...

Industries: Drug and Medication | Countries: Turkey, Europe, United States

Autoimmune Drug Focus NOVEMBER 2014

Autoimmune Drug Focus NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 20 pages

Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market Industry Brief - Novo Nordisk Invests In New Danish Laboratory Facility Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance Industry Brief - Paediatric Type I Diabetes Diamyd/GABA Combination ...

Industries: Drug and Medication | Countries: Europe, Canada, World, United Kingdom, Sweden, Germany, Denmark, Japan, United States

World Generic Markets 24 NOVEMBER 2014

World Generic Markets 24 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 16 pages

Industry Trend Analysis - Acquisition Of Allergan Will Transform Actavis Industry Brief - Teva Launches Celecoxib In Canada Industry Brief - Beximco Gains Canadian GMP Approval Industry Brief - FDA Rescinds Ranbaxy Exclusivities Creating Opportunity For Dr Reddy's And Endo Industry Brief - Sucampo Files ...

Industries: Drug and Medication | Countries: World, Canada, United States, United Kingdom, Switzerland, Europe, Saudi Arabia, North America

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: Czech Republic, Italy, Europe

TAD Pharma GmbH SWOT Analysis, Strategy, Revenues and Profits

TAD Pharma GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: Switzerland, Europe, Portugal, Ireland, Hungary, Greece, Germany, Cyprus, Austria, Albania, Yemen, Taiwan, Syrian Arab Republic, Lebanon, Jordan, China, Asia

Cancer Drug News 10 NOVEMBER 2014

Cancer Drug News 10 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 12 pages

Industry Trend Analysis - Dendreon Unlikely To Find Buyer With Provenge's Underperformance Industry Brief - Altor Initiates Development Of ALT-803 In r/r MM Supported By Phase II SBIR Grant Industry Brief - AstraZeneca/Pharmacyclics/Janssen Enter Immuno-Oncology Clinical Trial Collaboration Industry ...

Industries: Drug and Medication | Countries: Europe, Asia, World

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

EU: Lactams From Heterocyclic Compounds - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the EU Market of Lactams From Heterocyclic Compounds. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify ...

Industries: Drug and Medication | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.